A chance finding in a lab is paving the way for novel approaches to flu prevention. Scientists investigating influenza replication found distinct strategies used by various flu strains to enter human cells. By focusing on the molecules these viruses depend on, researchers can potentially block them from spreading and multiplying.
Diverse Viral Strategies
Research highlighted that several strains, like H1N1 and H3N2, adopt different tactics to invade cells. Currently, available flu tests cannot differentiate between these strains, resulting in identical clinical treatments. Despite existing vaccines and antivirals, there is a significant need for more effective medications to prevent the virus from moving from cell to cell. Dr. Emily Bruce from the University of Vermont underscored this gap in treatment.
Key Findings
The study, published in The Journal of Virology, initially aimed to chart the movement of viral RNA within cells. During this process, the team discovered an unexpected cellular pathway that obstructed the virus from accessing lung cells. Notably, depleting a protein called Rab11B hindered H3N2 viruses, while H1N1 remained unaffected.
“You don’t get sick when a virus is in one cell,” said Dr. Bruce. “You get sick because it spreads to more cells.”
Challenging Assumptions
The experiments dismantled the belief that all flu viruses enter cells identically. The team employed reverse genetics to determine that H3N2 relies on a unique role of Rab11B for cellular entry. This insight contradicts the previous assumption regarding viral entry mechanisms.
Further studies are essential to confirm the safety and efficacy of blocking Rab11B in the human respiratory system. Researchers aim to explore whether this dependency is a distinctive feature of H3N2 or a characteristic of current flu strains.
Khloe Quill, a lifestyle production assistant at Fox News Digital, reported the findings as part of the health story coverage.
Leave a Reply